Finally, total and acetylated XBP1s protein levels were significantly higher in the liver tissues of NAFLD patients than in those of healthy controls, suggesting an inhibitory role of Sirt6-mediated deacetylation of XBP1s in NAFLD pathogenesis. Here, SIRT6 is linked to metabolic dysfunction-associated steatotic liver disease.